Responsible for strategic engagement on key legislative and regulatory matters; building and maintaining relationships with policymakers, staff, and stakeholders; developing strategies to advocate the company’s position on critical government matters; and successfully shaping the outcomes of Indivior’s public policy priorities.

Collaborate with multiple cross-functional teams, including Marketing, Account Team, Government Affairs, Medical, and other internal teams, to ensure the strategic pull-through of the team's critical commercial priorities.

Retained based on knowledge of the Opioid Epidemic to work on a pre-release project for a multibillion-dollar pharma company regarding a highly complex, non-traditional market with government, community groups, and pharmacy supply chain as customers. Advising brand planning team on ecosystem intricacies and assembling and managing an advisory panel. Creating and managing a team of up to 15 government affairs specialists to engage states on legislation, regulatory affairs, and manage purchasing entities within state government. - Enabled a Government Markets Account Profiling comprehensive analysis of all 50 states for pre-launch strategy and planning.

Recruited as this VC-backed company’s most senior commercial executive to build and lead a commercial organization for a producer of an at-home medication disposal system. Hired and trained 4 outside sales professionals and managed 2 inside sales reps. Advised on government affairs matters.• Generated nearly $10M revenue in under a year. • Laid groundwork for significant growth by defining government market strategy, creating message/detail deck, testing messaging with stakeholders, and recruiting/training the right sales team to execute on messaging.• Changed culture and focus from transactional product sales to consultative partnerships and from a reactive sales position to proactive outreach to highest opportunity customers in the nation.• Championed Health Economic Outcomes Research to enable engagement of sophisticated healthcaresystems, potentially doubling company’s book of business while generating recurring sales.

Helped position company as market leader resulting in acquisition by Emergent BioSolutions in 2018 at a tremendous profit. Recruited by CCO to drive pull-through activities to accelerate sales of Naloxone HCI (NARCAN) and address regulatory hurdles in a young, entrepreneurial commercial organization.Guided up to 6 community field directors (sales reps) garnering sales team support without formal authority.Developed Federal relationships and managed ongoing Federal accounts. Participated on multiple external task forces with state leaders to address opioid epidemic.Gained deep understanding of federal grants, community distribution and the public health market.Note: This was a new organization, and we, the senior leadership team, molded it as a reflection of ourselves. Not only was it the most impactful product I have ever worked with, I co-defined its strategy. Highlights include:• Despite no prior government affairs experience, executed multi-faceted strategy that increased sales 453% YOY.• Seeded and stewarded co-prescribing legislation that was passed in 5 states. Estimated increase inprescriptions = 290K ($29M) in first years of passage. Tactics were adopted companywide.• Tracked and maneuvered into $1.5B+ in Federal government funding stemming from multiple agencies.• Navigated thorny politics and complexities to assemble supportive coalitions (lobbyist consultants,community organizations, KOLs) that effectively engaged legislators on company’s behalf.• Secured key entry point to national stockpile through BARDA, opening doors to numerous biodefenseagencies.• Grew VHA business an average of 6% YOY.• Led internal team that engaged professional boards, associations and community groups to createawareness of new laws and energize prescribers to comply with legislation.

Promoted to define and execute a new role leading managed care initiatives in 6 regions (20 states) across 3 business units (Sleep, Pain, Hematology/Oncology). Quickly rose to #2 ranking on managed care team despite no prior managed care experience.Managed relationships with State FFS Medicaid, Managed Medicaid, PBMs, local VHA VISNs and largest payers in Western states.Collaborated with field sales leadership to leverage access opportunities.• Rapidly shaped the new role, scaled team to 8 people, adopted SOP for payer/sales team collaboration, and mitigated perceived payer issues that limited product utilization.• Restored strong relationships with payers after years of sharp price increases.• Orchestrated payer activities for new product launches, including Xyrem REMS and Defitelio(R).

Led a 10-person sales team for Jazz Pharmaceuticals’ $65M/year Psychiatry Business Unit Western Sales Region (8 states). Managed and inspired teams that ranked #1 for 5 consecutive years.Supported and steered execution of sales/marketing strategy for a new organization and an impactful product (FazaClo), as well as 34% of national market of 4 separate psychiatry-based products.Appointed to transition leadership team during Azur/Jazz integration. National lead for Challenger Sales Model roll out.• Five-time Sales Manager of the Year; maintained top ranking despite taking on a new team and different products.• Drove newly launched FazaClo HD® regional sales to 24.8% above national average, adding $40M in sales. • Developed Sales Representatives for promotions to Marketing Manager and Sr. Sales Consultant; 4 consecutive years of Representative of the Year awards originated from the West Region.

Became a top producer selling a branded product in a genericized space, and advanced to senior sales rep. Primary product: FazaClo.• Transformed territory into the fastest growing geography 3 years in a row to become the 2nd largest volume in the nation. 31% YOY growth in 2009.• Awards: President’s Club, Rookie of the Year, Sales Rep of the Year.

In first pharmaceutical role, quickly learned the business, worked with accounts to identify treatment refractory schizophrenia patients who could benefit from FazaClo®

CNS sales representative detailing schizophrenia product to Psychiatrists (Team/Product aquired by Azur Pharma)